Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology
Link
http://link.springer.com/content/pdf/10.1007/BF02936954.pdf
Reference30 articles.
1. Clissold SP, Edwards C. Acarbose, preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1988;35:214–243.
2. Puls W, Keup U, Krause HP, et al. Glucosidase inhibition: A new approach to the treatment of diabetes, obesity and hyperlipoproteinemia. Naturwissenschaften 1977;64:536–537.
3. Puls W, Krause HP. Delay of carbohydrate absorption by inhibitors of intestinal alpha-glucosidases. Adv Exp Med Biol 1979; 119:341–346.
4. Hanefeld M, Fischer S, Schulze J, et al. Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet alone. Diabetes Care 1991;14:732–737.
5. Hoffmann J, Spengler M. Efficacy of 24-week monotherapy with acarbose, glibenclamide or placebo in NIDDM patients. Diabetes Care 1994;17:561–566.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01
2. Lignan constituents with α-amylase and α-glucosidase inhibitory activities from the fruits of Viburnum urceolatum;Phytochemistry;2023-12
3. Iridoid constituents from the branches of Viburnum chinshanense and their inhibitory effects on α-amylase and α-glucosidase;Phytochemistry;2023-12
4. Natural α-glucosidase and α-amylase inhibitors from raspberry (Rubus corchorifolius L.) leaf-tea: Screening, identification and molecular docking analysis;LWT;2023-05
5. Reactive hypoglycemia owing to an intrahepatic congenital portosystemic shunt in an older patient;Diabetology International;2023-04-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3